NCT07541534 2026-04-21
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
Clinical Trials
3 trialsNCT07480681 2026-03-18
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
NCT07473726 2026-03-16
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting